Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B
2026-03-25 12:31:17 ET
More on healthcare stocks
- Merck & Co., Inc. (MRK) M&A Call Transcript
- Merck & Co., Inc. (MRK) Terns Pharmaceuticals, Inc. - M&A Call - Slideshow
- IHI: Pullback Creates A Buying Opportunity In High-Growth MedTech
- Terns Pharma shares surge on $6.7B Merck buyout deal at $53 per share
- Terns Pharma shares surge on reported $6B acquisition talks with Merck
Read the full article on Seeking Alpha
For further details see:
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7BNASDAQ: XLV
XLV Trading
-1.67% G/L:
$144.08 Last:
7,798,591 Volume:
$145.72 Open:



